Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.4680
-0.0070 (-1.47%)
At close: Oct 2, 2026, 4:00 PM EDT
0.4602
-0.0078 (-1.67%)
After-hours: Oct 2, 2026, 4:04 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $20.36 million as of October 2, 2026. Its market cap has decreased by -59.01% in one year.
Market Cap
20.36M
Enterprise Value
20.21M
1-Year Change
-59.01%
Ranking
Category
Stock Price
$0.47
ChartMarket Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $20.36M, an increase of 1,045.20%. That is a compound annual growth rate of 85.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 20.36M | -65.45% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NextCure | 23.30M |
| Cocrystal Pharma | 22.06M |
| TScan Therapeutics | 21.72M |
| Quoin Pharmaceuticals | 21.47M |
| Radiopharm Theranostics | 21.10M |
| SeaStar Medical Holding | 20.67M |
| Psyence Biomedical | 19.68M |
| Actuate Therapeutics | 19.67M |